Skip to main content

Survival Improves With Open Hysterectomy for Cervical Cancer

Medically reviewed by Carmen Pope, BPharm. Last updated on June 28, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, June 28, 2024 -- For patients with early-stage cervical cancer, disease-free and overall survival are lower for patients undergoing minimally invasive versus open radical hysterectomy, according to a study published online June 25 in the Journal of Clinical Oncology.

Pedro T. Ramirez, M.D., from the Methodist Hospital in Houston, and colleagues compared overall survival between open and minimally invasive radical hysterectomy among cervical cancer patients followed for 4.5 years. A total of 631 patients were enrolled: 319 and 312 were assigned to minimally invasive and open surgery, respectively; 289 and 274 underwent minimally invasive and open surgery, respectively.

The researchers found that at 4.5 years, disease-free survival was 85.0 and 96.0 percent in the minimally invasive and open groups, respectively (difference, −11.1 percent). Compared with open surgery, minimally invasive surgery was associated with a lower rate of disease-free survival (hazard ratio, 3.91). At 4.5 years, the rates of overall survival were 90.6 and 96.2 percent for the minimally invasive and open surgery groups, respectively (hazard ratio for death from any cause, 2.71).

"On the basis of these findings, patients undergoing radical hysterectomy for early cervical cancer should undergo open surgery as recommended by guidelines, and minimally invasive radical hysterectomy should only be performed in clinical trials," the authors write.

Several authors disclosed ties to the biopharmaceutical and medical device industries.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Precision-Guided Treatment Improves Outcomes for High-Risk Pediatric Cancer

FRIDAY, June 28, 2024 -- Precision-guided treatment improves outcomes for children with high-risk cancer, according to a study published online June 6 in Nature Medicine. Loretta...

Recommendations Issued for Advanced Imaging for Pediatric Patients in ED

THURSDAY, June 27, 2024 -- In a policy statement issued by the American Academy of Pediatrics and published online June 27 in Pediatrics, recommendations are presented for...

Rare Predicted Loss-of-Function Variants, Polygenic Risk Score Linked to Risk of A-Fib

THURSDAY, June 27, 2024 -- Rare predicted loss-of-function (pLOF) variants and a polygenic risk score (PRS) are associated with increased atrial fibrillation (AF) risk, according...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.